Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Cirrhosis, Familial, with Pulmonary Hypertension × regorafenib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Unresectable Locally Advanced or Metastatic Solid Tumors 1 HER2-positive Colorectal Cancer 1 Gastrointestinal Stromal Tumors 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Cholangiocarcinoma 1

Interventions

Leucovorin 3 Fluorouracil 3 Oxaliplatin 2 Folfox protocol 2 regorafenib 1 lenvatinib 1 donafenib 1 Surgical Procedures, Operative 1 Radiotherapy 1 Irinotecan 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06946849 2025-04-27

SED-RO-ICC

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡